Literature DB >> 21964438

Crosstalk between Raf/MEK/ERK and PI3K/AKT in suppression of Bax conformational change by Grp75 under glucose deprivation conditions.

Ling Yang1, Weiwei Guo, Qunling Zhang, Hongyan Li, Xiaoyu Liu, Yunlong Yang, Ji Zuo, Wen Liu.   

Abstract

During glucose deprivation (GD)-induced cellular stress, the molecular chaperone glucose-regulated protein 75 (Grp75)/Mortalin/PBP74/mtHSP70 (hereafter termed "Grp75") plays an important role in the suppression of apoptosis by inhibiting the Bax conformational change that delays the release of cytochrome c. The molecular pathways by which it carries out these functions are still unclear. We hypothesize that the anti-apoptotic effect by the overexpression of Grp75 was through the signal of AKT activated by classic phosphoinositide 3-kinase (PI3K) and also involved PI3K-independent pathways. Using the PC12 cell GD model, we demonstrated a novel mechanism of Grp75 activating AKT, which may be PI3K independent and associated with Raf/MEK (mitogen-activated protein kinase/ERK kinase)/ERK signaling. The PI3K inhibitor LY294002 did not influence the activation of AKT by the Grp75 overexpression under GD; however, the MEK inhibitor U0126 dramatically inhibited AKT phosphorylation in the same assay. In addition to the PI3K/AKT signal pathway, Grp75 overexpression also inhibited the Bax conformational change through the Raf/MEK/ERK signal pathway. In conclusion, Grp75 overexpression in activating AKT can be PI3K independent and associated with Raf/MEK/ERK signaling under GD. At the same time, PI3K may also crosstalk with Raf-1, in which the prosurvival signal of PI3K maintains the expression of Raf-1. The activated AKT and extracellular signal-regulated protein kinases 1 and 2 by Grp75 inhibited the Bax conformational change and subsequent apoptosis.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21964438     DOI: 10.1016/j.jmb.2011.09.009

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  26 in total

1.  Functional significance of point mutations in stress chaperone mortalin and their relevance to Parkinson disease.

Authors:  Renu Wadhwa; Jihoon Ryu; Hyo Min Ahn; Nishant Saxena; Anupama Chaudhary; Chae-Ok Yun; Sunil C Kaul
Journal:  J Biol Chem       Date:  2015-02-02       Impact factor: 5.157

2.  Low-after-high glucose down-regulated Cx43 in H9c2 cells by autophagy activation via cross-regulation by the PI3K/Akt/mTOR and MEK/ERK1/2 signal pathways.

Authors:  Yaguang Bi; Guangyu Wang; Xiangdong Liu; Meng Wei; Qingyong Zhang
Journal:  Endocrine       Date:  2017-02-08       Impact factor: 3.633

3.  GRP75 Involves in Retinal Ganglion Cell Apoptosis After Rat Optic Nerve Crush.

Authors:  Gaoming Zhang; Mei Han; Xiaodong Wang; Aiping Xiao
Journal:  J Mol Neurosci       Date:  2015-01-20       Impact factor: 3.444

Review 4.  Why is Mortalin a Potential Therapeutic Target for Cancer?

Authors:  A-Rum Yoon; Renu Wadhwa; Sunil C Kaul; Chae-Ok Yun
Journal:  Front Cell Dev Biol       Date:  2022-06-29

5.  CpG-ODN, the TLR9 agonist, attenuates myocardial ischemia/reperfusion injury: involving activation of PI3K/Akt signaling.

Authors:  Zhijuan Cao; Danyang Ren; Tuanzhu Ha; Li Liu; Xiaohui Wang; John Kalbfleisch; Xiang Gao; Race Kao; David Williams; Chuanfu Li
Journal:  Biochim Biophys Acta       Date:  2012-08-16

6.  Identification and functional characterization of nuclear mortalin in human carcinogenesis.

Authors:  Jihoon Ryu; Zeenia Kaul; A-Rum Yoon; Ye Liu; Tomoko Yaguchi; Youjin Na; Hyo Min Ahn; Ran Gao; Il-Kyu Choi; Chae-Ok Yun; Sunil C Kaul; Renu Wadhwa
Journal:  J Biol Chem       Date:  2014-07-10       Impact factor: 5.157

7.  Structural studies of UBXN2A and mortalin interaction and the putative role of silenced UBXN2A in preventing response to chemotherapy.

Authors:  Sanam Sane; Ammara Abdullah; Morgan E Nelson; Hongmin Wang; Subhash C Chauhan; Samuel S Newton; Khosrow Rezvani
Journal:  Cell Stress Chaperones       Date:  2015-12-04       Impact factor: 3.667

8.  Targeting Mortalin by Embelin Causes Activation of Tumor Suppressor p53 and Deactivation of Metastatic Signaling in Human Breast Cancer Cells.

Authors:  Nupur Nigam; Abhinav Grover; Sukriti Goyal; Shashank P Katiyar; Priyanshu Bhargava; Pi-Chao Wang; Durai Sundar; Sunil C Kaul; Renu Wadhwa
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

9.  Cross talk of the first-line defense TLRs with PI3K/Akt pathway, in preconditioning therapeutic approach.

Authors:  Fatemeh Pourrajab; Mohammad Baghi Yazdi; Mojtaba Babaei Zarch; Mohammadali Babaei Zarch; Seyedhossein Hekmatimoghaddam
Journal:  Mol Cell Ther       Date:  2015-05-30

10.  Mortalin/glucose-regulated protein 75 promotes the cisplatin-resistance of gastric cancer via regulating anti-oxidation/apoptosis and metabolic reprogramming.

Authors:  Yi Dai; Fan Li; Yuwen Jiao; Guoguang Wang; Tian Zhan; Yunwei Xia; Hanyang Liu; Haojun Yang; Jianping Zhang; Liming Tang
Journal:  Cell Death Discov       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.